These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8983700)

  • 1. [Clinical and immunological bases of effectiveness of the use of endolymphatic therapy in the treatment of patients with pleural empyema].
    Feshchenko IuI; Pristaĭko IaI; Opanasenko NS; Fedoruk NI
    Klin Khir; 1996; (4):24-6. PubMed ID: 8983700
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of antibiotic therapy on the immune status of patients with nonspecific lung diseases complicated by pleural empyema].
    Opanasenko NS; Pristaĭko IaI; Karnakh RI; Voloshin IaM
    Lik Sprava; 1999; (1):85-8. PubMed ID: 10424009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of acute pulmonary abscess complicated by pleural empyema and bronchial fistula].
    Opanasenko NS
    Klin Khir; 1995; (11-12):11-2. PubMed ID: 8768224
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytokines in complex treatment of posttraumatic empyema of the pleura].
    Abakumov MM; Danielian ShN; Bulava GV
    Khirurgiia (Mosk); 2005; (2):4-8. PubMed ID: 15798721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of endolymphatic antibiotic therapy on the status of cellular immunity in peritonitis].
    Toskin KD; Starosek VN; Popov SN; Lebedev AI
    Klin Khir (1962); 1991; (4):7-9. PubMed ID: 1881089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action of cyclophosphane and degranol on the T- and B-lymphocyte populations in the lymph nodes when administered endolymphatically].
    Davydov VF; Kuzin VB
    Farmakol Toksikol; 1986; 49(2):31-5. PubMed ID: 3486778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The reasons for the application of endolymphatic therapy in the treatment of purulent lung diseases, complicated by empyema of the pleura].
    Pristaĭko IaI; Feshchenko IuI; Opanasenko NS
    Klin Khir; 1997; (5-6):24-5. PubMed ID: 9440964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clarithromycin in experimental empyema by multidrug-resistant Pseudomonas aeruginosa.
    Tsovolou EC; Tzepi IM; Spyridaki A; Tsaganos T; Karagianni V; Menenakos E; Liakou P; Sabracos L; Zografos G; Giamarellos-Bourboulis EJ
    APMIS; 2014 Jan; 122(1):68-75. PubMed ID: 23656439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medical-and-economic substantiation of rational antibacterial therapy for patients with pleural empyema in the conditions of military medical institutions].
    Ivanov FV; Kotiv BN; Barinov OV; Suborova TN; Ivchenko EV
    Voen Med Zh; 2013 Mar; 334(3):12-4. PubMed ID: 23808209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Home intravenous antibiotic therapy of empyema and lung abscess: safety and efficacy].
    Pardos-Gea J; Maza Ú; Pérez-López J; San José Laporte A
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):237-9. PubMed ID: 21354662
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunity in bronchial asthma after intrapulmonary administration of metipred].
    Provotorov VM; Kuznetsov SI; Poliakova TA
    Sov Med; 1991; (10):48-51. PubMed ID: 1666200
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of pleural cavity in pleural empyema].
    Opanasenko NS
    Klin Khir; 1997; (5-6):64-8. PubMed ID: 9440986
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal thoracic empyema involving Campylobacter rectus: A case report.
    Noël A; Verroken A; Belkhir L; Rodriguez-Villalobos H
    Anaerobe; 2018 Feb; 49():95-98. PubMed ID: 29325875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of clarithromycin in experimental pleural empyema model fluid.
    Liapakis IE; Light RW; Pitiakoudis MS; Karayiannakis AJ; Giamarellos-Bourboulis EJ; Ismailos G; Anagnostoulis S; Simopoulos CE; Bouros DE
    Respiration; 2005; 72(3):296-300. PubMed ID: 15942299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of drugs on immunohematological indices in vitro].
    Belotskiĭ SM; Snastina TI; Churikov AN
    Ter Arkh; 1982; 54(9):94-6. PubMed ID: 6983737
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinico-immunological evaluation of the efficacy of treatment of patients with furunculosis].
    Savitskaia LN
    Vestn Dermatol Venerol; 1983 Mar; (3):4-9. PubMed ID: 6602435
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of pleural empyema: don't miss the point!
    Froudarakis ME; Bouros D
    Respiration; 2013; 86(4):277-9. PubMed ID: 23988456
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics of medically and surgically treated empyema patients: a retrospective cohort study.
    Dusemund F; Weber MD; Nagel W; Schneider T; Brutsche MH; Schoch OD
    Respiration; 2013; 86(4):288-94. PubMed ID: 23988906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Administration of medications via a lymphatic vessel in the treatment of diffuse peritonitis and sepsis].
    Pristaĭko IaI
    Vestn Khir Im I I Grek; 1985 Jan; 134(1):68-70. PubMed ID: 3992808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empyema thoracic from Salmonella choleraesuis.
    Lai CC; Lee LN; Hsueh PR; Yu CJ; Yang PC
    Emerg Infect Dis; 2005 Sep; 11(9):1493-4. PubMed ID: 16673520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.